UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology ▲ |
---|---|---|---|---|---|
A0A8C3ILH3 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3F9M5 | Hyaluronidase |
|
1 | 0 |
|
A0A8C3IX80 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3IR90 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C3HVD7 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C3IGS6 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3ITA2 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
2 | 0 |
|
A0A8C3IYI3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3P9J7 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A8C3II58 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3INE1 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8C3IJG8 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C3IX79 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C3I6P5 | Hyaluronidase |
|
1 | 0 |
|
A0A8C3FAX0 | Noggin |
|
1 | 0 |
|
A0A8C3I054 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C3FHR9 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C3I7Z6 | Hyaluronidase |
|
1 | 0 |
|
A0A8C3PEE1 | Potassium two pore domain channel subfamily K member 16 |
|
1 | 0 |
|
A0A8C3H727 | Hyaluronidase |
|
1 | 0 |
|
A0A8C3IYY1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3HPP5 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A8C3II00 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C3P702 | Rhodopsin |
|
2 | 0 |
|
A0A8C3J143 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025